Health Canada Grants Special Access to Restricted Drugs for Psychedelic Therapy
New amendment reverses a 2013 Health Canada policy that prevented “a letter of authorization for a new drug that is or that contains a restricted drug.”
New amendment reverses a 2013 Health Canada policy that prevented “a letter of authorization for a new drug that is or that contains a restricted drug.”
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.